Skip to main content
. 2018 Sep 8;7(10):670–677. doi: 10.1002/psp4.12316

Figure 3.

Figure 3

Mavrilimumab: one‐compartment model in Eq.  (1) in which the base parameter values are in Table  1. Each plot shows a sensitivity analysis where the parameter in the title is changed from 0.1‐fold to 10‐fold. The dot shows critical concentration. CL, clearance; V max, maximal rate of saturable elimination.